Results 1 to 10 of about 199 (102)

Proptosis in Otorhinolaryngology: An Overview [PDF]

open access: yesInternational Archives of Otorhinolaryngology, 2021
Introduction Ear, nose and throat (ENT)pathologies can present with proptosis as the early manifestation. The majority of ENT pathologies present with ocular manifestations, due to close anatomical relationship. Objective To study proptosis in
Novshaba Nazeer, Phani Bhushan Ivaturi
doaj   +2 more sources

Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves’ disease: a systemic review [PDF]

open access: yesFrontiers in Endocrinology, 2023
AimTo probe the appropriate iodine nutritional status for patients with Graves’disease (GD) hyperthyroidism and on antithyroid drugs (ATD) or after drugwithdrawal.MethodStudies were retrieved from three databases (Embase, Medline, and Cochrane Library ...
Qingxing Xie   +5 more
doaj   +2 more sources

Concurrence of Myasthenia Gravis and Thyroid Disorders [PDF]

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2019
Introduction. Both myasthenia gravis (MG) and autoimmune thyroid diseases (AITDs) are autoimmune diseases. Graves’disease (GD) is the most common AITD reported to be associated with MG. Currently, there is limited data on prevalence and clinical features/
Sasivimol Virameteekul   +3 more
doaj   +2 more sources

Immune checkpoint inhibitor-related type 1 diabetes incidence, risk, and survival association. [PDF]

open access: yesJ Diabetes Investig
Collectively, the results of this study demonstrate the precise incidence and risk factors of immune checkpoint inhibitor‐related type 1 diabetes mellitus (ICI‐T1DM). The development of ICI‐T1DM, like other immune‐related adverse events, is associated with higher survival rates.
Kamitani F   +10 more
europepmc   +2 more sources

Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves’ disease in a Chinese Han population [PDF]

open access: yesBMC Medical Genetics, 2018
Background Single-nucleotide polymorphism (SNP) haplotype and SNP-SNP interactions of CTLA-4 and CD40 genes, with susceptibility to Graves’ disease (GD), were explored in a Chinese Han population.
Xiaoming Chen   +8 more
doaj   +2 more sources

A Study of Autoimmune Polyglandular Syndrome (APS) in Patients with Type1 Diabetes Mellitus (T1DM) Followed Up at a Teritiary Care Hospital [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Background: Type1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing β cells and is characterized by the presence of insulitis and β-cell autoantibodies.
Shaheen Banu Shaikh   +3 more
doaj   +2 more sources

A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease. [PDF]

open access: yesPLoS ONE, 2013
T-helper (Th) 22 and Th17 cells are involved in the pathogenesis of autoimmune diseases. However, their roles in the pathogenesis of Graves'disease (GD) are unclear.
Di Peng   +4 more
doaj   +2 more sources

Hypocalcemia and Fahr syndrome in a patient with Graves'disease: Difficult etiological diagnosis

open access: yesIndian Journal of Endocrinology and Metabolism, 2016
Ibtissem Oueslati   +3 more
doaj   +3 more sources

Лечение первичного гипотиреоза: нерешенные вопросы

open access: yesКлиническая и экспериментальная тиреоидология, 2015
Primary hypothyroidism is one of the most common endocrine disorders. According to modern concepts, replacement monotherapy with levothyroxine (L-T4) is the treatment of choice in primary hypothyroidism.
Tatyana Borisovna Morgunova   +2 more
doaj   +1 more source

Endogenous Glycine Formation in Myopathies and Graves'Disease

open access: yesExperimental Biology and Medicine, 1933
The relation between glycine and creatin metabolism, first pointed out by Brand1 and his associates, and extended by the therapeutic investigations of Milhorat, Thomas, and Techner,2, 3 makes the q...
E. Shorr, H. B. Richardson, H. G. Wolff
openaire   +1 more source

Home - About - Disclaimer - Privacy